Lara, Olivia D.
Krishnan, Santhoshi
Wang, Zhihui http://orcid.org/0000-0001-6262-700X
Corvigno, Sara
Zhong, YanPing
Lyons, Yasmin
Dood, Robert
Hu, Wei
Qi, Lisha
Liu, Jinsong
Coleman, Robert L.
Westin, Shannon N.
Fleming, Nicole D.
Cristini, Vittorio
Rao, Arvind
Burks, Jared http://orcid.org/0000-0002-6173-9074
Sood, Anil K.
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RP150578, RP170719, RP210214, CPRIT RP170719, CPRIT RP150578)
American Cancer Society (RSG-16-005-01)
National Science Foundation (DMS-1716737)
U.S. Department of Health & Human Services | NIH | Center for Scientific Review (1U01CA196403, 1U01CA213759, 1R01CA226537, 1R01CA222007, and U54CA210181)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1U01CA196403, 1U01CA213759, 1R01CA226537, 1R01CA222007, and U54CA210181)
Frank McGraw Memorial Chair in Cancer Research
Article History
Received: 1 April 2019
Accepted: 18 October 2019
First Online: 26 November 2019
Competing interests
: A.K.S. is an advisor for Kiyatec, Merck, is a stockholder in BioPath, and received research funding from M-Trap. R.L.C. received research funding from Abbvie, Janssen, Genmab, Merck, Clovis, AstraZeneca, Roche/Genentech, V-Foundation, and Gateway Foundation and is a consultant to Ararvive, Abbvie, Roche/Genentech, Oncomed, Merck, AstraZeneca, Tesaro, Immunogen, Janssen, Gamamab, and Genmab. S.N.W. has received research support from AstraZeneca, Clovis, Tesaro, Bayer, Roche/Genentech, ArQule, Novartis, and Cotinga Pharmaceuticals, Inc. and is a consultant to AstraZeneca, Clovis, Tesaro, Merck, Pfizer, and Rocke/Genentech.